Michel Nussenzweig is the Zanvil A. Cohn and Ralph M. Steinman Professor and a senior physician at The Rockefeller University. He is also the head of the university’s Laboratory of Molecular Immunology and the director of the Christopher Browne Center for Immunology and Immune Diseases. Nussenzweig’s laboratory studies the molecular aspects of the immune system’s innate and adaptive responses using a combination of biochemistry, molecular biology, and genetics.
His work on adaptive immunity focuses on B lymphocytes and antibodies to HIV-1, while his studies of innate immunity focus on dendritic cells. His work is leading to new antibody-based therapies for infections by HIV and the novel SARS-CoV-2 coronavirus, among other viruses. He holds a BA from New York University, a PhD from The Rockefeller University and an MD from New York University School of Medicine.
Organized by Janelia’s Sarada Viswanathan and Loren Looger, the Science of COVID-19 seminar series brings in outside experts, covers papers and preprints, and highlights local efforts in testing, production, and analysis.
LEARN MORE: janelia.org/scienceofcovid19
